Skip to main content

Table 1 Summary of the conflicting data on QTc interval in adults and in infants

From: Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options

Group

Reference

Characteristic

Anti-SSA/Ro-positive group

Control group

P

Infants

[2]

No. of patients

21

7

 
  

Age (days)

90

7

NA

  

QTc (ms)

442 ± 35

403 ± 16

0.001

 

[3]

No. of patients

38

7

 
  

Age (months)

65.4

1.8

NA

  

QTc (ms)

379 ± 26

332 ± 20

<0.0001

 

[8]

No. of patients

58

85

 
  

Age (days)

13 ± 14

15 ± 16

0.31

  

QTc (ms)

397 ± 27

395 ± 25

0.57

Adults

[9]

No. of patients

31

26

 
  

Age (years)

41 ± 15

49 ± 13

NA

  

QTc (ms)

445 ± 21

419 ± 17

0.000005

 

[20]

No. of patients

49

62

 
  

Age (years)

46

44

NS

  

QTc (ms)

411 ± 19

403 ± 24

0.06

 

[21]

No. of patients

32

57

 
  

Age (years)

37 ± 11

38 ± 12

0.58

  

QTc (ms)

409 ± 30

409 ± 28

0.78

  1. NA, not available; NS, not significant. Data are presented as means ± SD when available.